Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-18

Clinical Trial Update: A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

View source ↗

Summary

Pfizer's real-world study in Israel evaluated how palbociclib is used and what outcomes patients experience in metastatic breast cancer; the study is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Breast Cancer | Status: COMPLETED | Results posted: 2023-08-18